Funds holding Hybio Pharmaceutical Co Ltd
ISIN CNE1000011T7 · China
- Fund holders
- 6
- Of which ETFs
- 1 5 other funds
- Value held
- 6.2M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 885,100 | 2.7M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 802,991 | 2.5M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 240,100 | 732.8K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 43,100 | 131.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 42,400 | 128.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 27,900 | 85.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | -1 | 2,041,591 | -1.1 % |
| 2026Q1 | 7 | 0 | 2,063,391 | -1.5 % |
| 2025Q4 | 7 | +1 | 2,095,391 | -1.4 % |
| 2025Q3 | 6 | +1 | 2,124,691 | +3.6 % |
| 2025Q2 | 5 | 0 | 2,050,791 | -1.0 % |
| 2025Q1 | 5 | 0 | 2,071,191 | -0.0 % |
| 2024Q4 | 5 | 0 | 2,072,191 | 0.0 % |
| 2024Q3 | 5 | 0 | 2,072,191 | -1.9 % |
| 2024Q2 | 5 | +4 | 2,112,491 | +2,071.1 % |
| 2024Q1 | 1 | -5 | 97,300 | -95.7 % |
| 2023Q4 | 6 | 2,245,991 |
Cite this page
Titelia. "Funds holding Hybio Pharmaceutical Co Ltd". https://titelia.com/en/stocks/hybio-pharmaceutical-co-ltd-CNE1000011T7